Skip to main content

Table 4 Clinical importance of potentially inappropriate prescribing criteria according to the expert panel

From: Detection of potentially inappropriate prescribing in the very old: cross-sectional analysis of the data from the BELFRAIL observational cohort study

Examples

   

Major clinical importance (n = 43)

Modification of the treatment according to this criteria may prevent serious morbidity, including readmission, serious organ dysfunction, serious adverse drug event

  
  

Criterion: START-PIP “Angiotensin converting enzyme (ACE) inhibitor with chronic heart failure”.

Context: The GP reports chronic heart failure, with marked limitation of physical activity and dyspnea, and a recent episode of congestive heart failure.

  

Criterion: STOPP-PIP “Calcium channel blockers with NYHA class III or IV heart failure”/Beers- PIP “Diltiazem in heart failure”.

Context: The medical history and the clinical examination confirm that the patient has NYHA class III heart failure.

  

Criterion: Beers- PIP “Anticholinergics in dementia and cognitive impairment”.

Context: The patient has cognitive impairment (MMSE = 22/30a) and takes several drugs with anticholinergic properties (amisulpride, trihexyfenidyl).

Moderate clinical importance (n = 33)

Modification of the treatment according to this criteria brings care to a more acceptable and appropriate level of practice or that may prevent an adverse drug event of moderate importance

  
  

Criterion: START-PIP “Statin therapy in diabetes mellitus if coexisting major cardiovascular risk factors present”.

Context: The patient is 87 years, and still has good cognitive and functional status. She has diabetes, hypertension and hypercholesterolemia.

  

Criterion: STOPP-PIP “Long-term long-acting benzodiazepines”.

Context: The patient has been taking 8mg prazepam every day for more than a month. She has low fall risk (Tinetti score 26/28b) but she has cognitive impairment (MMSE=18/30).

  

Criterion: STOPP-PIP/Beers-PIP “Aspirin in primary cardiovascular prevention”.

Context: The patient has no history of coronary, cerebral or peripheral vascular symptoms or occlusive event.

  

Criterion: Beers- PIP “Tertiary tricyclic antidepressants”.

Context: The patient is on clomipramine for “depressive tendencies” according to the GP. The GDS-15 score is low (3/15c). Non pharmacologic or safer alternatives are available.

Minor clinical importance (n = 2)

Modification of the treatment according to these criteria brings no benefit or minor benefit, depending on professional interpretation

  
  

Criterion: Beers-PIP “Avoid antiarrhythmic drugs as first-line treatment of atrial fibrillation”.

Context: This patient receives amiodarone and does not suffer from any side effect of this drug.

  

Criterion: Beers-PIP “Avoid long duration sulfonylurea”.

Context: The patient is on gliclazide extended release formula. He is intolerant to metformine. No hypoglycemia were reported.

Deleterious clinical importance (n = 1)

Modification of the treatment according to this may lead to adverse outcome.

  
  

Criterion: START-PIP “Statin therapy in diabetes mellitus if coexisting major cardiovascular risk factors present”.

Context: The patient has a documented allergy to statins.

Non applicable (n = 40)

The criterion is not applicable to the individual context of the patient.

  
  

Criterion: START-PIP “beta-blocker with chronic stable angina”.

Context: The patient had a single episode of suspected angina in the past, and he has asthma.

  

Criterion: START-PIP “Aspirin therapy in diabetes mellitus if coexisting major cardiovascular risk factors present”.

Context: The patient is already on anti-vitamin K and he has no acute coronary disease.

  

Criterion: STOPP-PIP “Any duplicate drug class prescription”.

Context: The prescription includes a patch of nitroglycerin and tablets of isosorbide dinitrate. However, in his notes, the GP specifies that the patient uses the tablets “as needed” only.

  

Criterion: STOPP-PIP “Long-term use of NSAID for symptom relief of mild osteoarthritis”.

Context: The 83 year old patient has chronic knee pain despite the use of paracetamol. Unfortunately, his severe respiratory and cardiac status is a contra-indication to surgery and he is intolerant to alternatives to NSAID. He is on proton-pump inhibitor.

  

Criterion: Beers-PIP “Avoid antipsychotics in dementia & cognitive impairment”.

Context: This patient has cognitive impairment but also a long story of psychiatric disorders.

  

Criterion: Beers-PIP “Avoid benzodiazepines for the treatment of insomnia, agitation, or delirium”.

Context: This patient received alprazolam to improve her sleep in a context of severe chronic anxiety.

  1. Abbreviation: GDS-15 geriatric depression scale, GP general practitioner, MMSE mini mental state examination, NSAID non-steroidal anti-inflammatory drugs, NYHA New York Heart Association Functional Classification, PIP potentially inappropriate prescribing
  2. aMMSE<25 was considered as “cognitive impairment”
  3. bTinetti score >24 was considered as “low fall risk”
  4. cGDS-15 score >4 was considered as “possible depression”